» Articles » PMID: 38163036

The Effect of Group Training or Spinal Orthosis on Quality of Life and Potential Plasma Markers of Pain in Older Women With Osteoporosis. A Randomized Controlled Trial

Overview
Date 2024 Jan 1
PMID 38163036
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Primary purpose was to examine the effects of exercise and use of a spinal orthosis on quality of life (QoL). Secondary, to explore the effects of above-mentioned interventions on plasma levels of potential markers of pain: substance P (SP), calcitonin gene-related peptide (CGRP), and interleukin-6 (IL-6).

Design: Randomized controlled trial.

Setting: Community-dwelling women in Stockholm.

Participants: A total of 113 women aged 60-93 years suffering from back pain and self-reported osteoporosis (n=113).

Interventions: The randomized controlled trial was 3-armed: participation in an equipment exercise group, treatment with an activating spinal orthosis or controls. The intervention time was 6 months.

Main Outcome Measures: QoL (QUALEFFO-41 and SF-36), plasma levels of SP, CGRP, and IL-6 measured at baseline and after 6 months in all 3 arms.

Results: No improvement of QoL was found. Comparing change in mobility (QUALEFFO-41), the effect in least squares means was lower in the spinal orthosis group compared with controls. In the exercise group, the role emotional score (SF-36) deteriorated during the intervention. Effect size varied between 0.02 and 0.6. There was no change in the levels of CGRP or SP, while IL-6 levels were lower at 6 months in the spinal orthosis group compared with the other groups. At least 1 previous vertebral fracture was verified by X-ray in 46 women.

Conclusion: The interventions showed none or negative effect on QoL, which was unexpected. The modest effect size may prompt a cautious interpretation. We found a lowering of IL-6 levels in the spinal orthosis group, but more studies are needed.

Citing Articles

Biochemical Mechanisms and Rehabilitation Strategies in Osteoporosis-Related Pain: A Systematic Review.

Iaconisi G, Mancini R, Ricci V, Donati D, Sconza C, Marvulli R Clin Pract. 2024; 14(6):2737-2758.

PMID: 39727804 PMC: 11674043. DOI: 10.3390/clinpract14060216.

References
1.
Stanghelle B, Bentzen H, Giangregorio L, Pripp A, Skelton D, Bergland A . Effects of a resistance and balance exercise programme on physical fitness, health-related quality of life and fear of falling in older women with osteoporosis and vertebral fracture: a randomized controlled trial. Osteoporos Int. 2020; 31(6):1069-1078. DOI: 10.1007/s00198-019-05256-4. View

2.
Kanis J, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A . Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int. 2000; 11(8):669-74. DOI: 10.1007/s001980070064. View

3.
Price D, McGrath P, Rafii A, Buckingham B . The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983; 17(1):45-56. DOI: 10.1016/0304-3959(83)90126-4. View

4.
Alin C, Grahn-Kronhed A, Uzunel E, Salminen H . Wearing an Activating Spinal Orthosis and Physical Training in Women With Osteoporosis and Back Pain: A Postintervention Follow-Up Study. Arch Rehabil Res Clin Transl. 2022; 3(4):100154. PMC: 8683839. DOI: 10.1016/j.arrct.2021.100154. View

5.
Wu H, Lin X, Long Y, Wang J . Calcitonin gene-related peptide is potential therapeutic target of osteoporosis. Heliyon. 2022; 8(12):e12288. PMC: 9758432. DOI: 10.1016/j.heliyon.2022.e12288. View